News
Fenja and Malin start their 3-month PharMetrX Industry Module 2 (I2) in Denmark
On 01 February. Our Research+ PhD student Fenja Klima and Training+ PhD student Malin Andersson are joining the pharmacometric group Novo Nordisk, one of our PharMetrX Industry Partner Consortium.
Fenja will work on modelling and simulation of treatment discontinuation, Malin will work on simulating outcome trials based on biomarkers. Their I2 internship takes place in Copenhagen Denmark from February to April 2025. We wish you a successful internship and many exiting first-hand insights to experience the life as a pharmacometrician in industry, Fenja and Malin!